The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for HO Bertrand


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.EBI
Universite Paris Descartes
Virtual screening workflow development guided by the"receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.EBI
Paris Descartes University
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.EBI
Parc Club Orsay Universit£
Novel Inhibitory Site Revealed by XAP044 Mode of Action on the Metabotropic Glutamate 7 Receptor Venus Flytrap Domain.EBI
Universite Paris Cite
Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.EBI
University Paris Descartes
Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.EBI
Faust Pharmaceuticals
Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin.EBI
University of Paris
Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.EBI
Paris Descartes University
Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites.EBI
University of Paris